Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists launch world’s first antimicrobial medical gloves
Researchers expect the gloves to eventually sell in their billions, as healthcare providers battle to fight infection and combat antimicrobial resistance.
Gloves a "game changer" for the healthcare industry

The world’s first non-leaching antimicrobial gloves were launched yesterday (31 May) in London.

The gloves contain a new active microorganism-killing molecule designed to prevent the spread of bacteria. Because the technology is built into the material, the gloves don’t need surface applications of further solutions or testing.

In independent testing, the gloves achieved a 99.9 per cent kill within just five minutes of contact. University of Nottingham microbiologist Richard James, who helped with the project, said the gloves will be a “game-changer” for the healthcare industry.

“I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future,” he said.

The gloves are the culmination of more than six years of research by Professor James, medical glove makers Hartalega Malaysia and development company Chemical Intelligence UK. They are expected to sell in their billions, as healthcare providers battle to fight infection and combat antimicrobial resistance.

“In the European Union alone, cross-contamination in hospitals results in 37,000 deaths a year at an additional cost of 7 billion euros,” said Mr Kuan Mun Leong, managing director of Hartalega Holdings. “By renovating a medical device that has not been remodelled in over 30 years, our innovation is set to make waves in the healthcare industry and save lives across the globe.”

Chemical Intelligence UK founder Rob Gross added: “After years of development, we are delighted to finally release this product to market and truly believe it will make a significant difference in the fight against healthcare-associated infections (HAIs). Like Hartalega, we have a passion for innovation and together we are the perfect partners to release this technology.”

Become a member or log in to add this story to your CPD history

New single-dose RHD-2 vaccine launched

News Story 1
 The first monovalent vaccine to be registered in Europe for the prevention of rabbit hemorrhagic disease type 2 (RHD-2) has been launched by animal health firm HIPRA.

ERAVAC is a single-dose injectable emulsion that can be administered without the need for reconstitution beforehand. The new presentation contains 10 vials with individual doses that can be given to companion rabbits from 30 days of age. 

Click here for more...
News Shorts
New canine and feline dentistry manual announced

A new canine and feline dentistry and oral surgery manual has been published by the BSAVA. Announcing the news on its website, the BSAVA said this latest edition contains new step-by-step operative techniques, together with full-colour illustrations and photographs.

‘This is a timely publication; veterinary dentistry is a field that continues to grow in importance for the general veterinary practitioner,’ the BSAVA said. ‘The manual has been fully revised and updated to include the most relevant, evidence-based techniques.’

The BSAVA Manual of Canine and Feline Dentistry and Oral Surgery, 4th edition is available to purchase from www.bsava.com/shop